Biotech

All Articles

Former Seagen chief executive officer unveils brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer last year for an ...

Ironwood creates further bid for $1B GI drug with brand-new subgroup data

.On the heels of a stage 3 gain that failed to excite entrepreneurs, Ironwood Pharmaceuticals is bac...

Novartis inks $150M deal for autoimmune molecular adhesive

.Don't cease Monte Rosa Rehabs right now. The Boston-based biotech is enjoying after authorizing a h...

Jade carves out exec group with Chinook veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...

Septerna goes social with upsized offering of $288M

.Commemorating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the openin...

AbbVie makes Richter wealthier, spending $25M to create invention pact

.AbbVie has actually returned to the resource of its antipsychotic powerhouse Vraylar looking for an...

GenSight gets in last full weeks of cash path as income stream edges out of reach

.GenSight Biologics is actually full weeks away from losing cash. Once again. The biotech only has s...

AZ licenses disposed of unusual health condition medication to Monopar Therapies

.Monopar Therapeutics is actually recuperating a drug coming from the scrap heap of AstraZeneca's un...

Arcus' brand-new HIF-2a information in kidney cancer cells mention prospective edge over Merck's Welireg, professionals say

.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of experts...

Roche bets as much as $1B to broaden Dyno genetics therapy shipment contract

.After forming a gene therapy alliance along with Dyno Rehabs in 2020, Roche is back for even more.I...